Buffalo Bills great Jim Kelly has completed his six weeks of treatment for the recurrence of oral cancer.The NFL football star got his last dose of radiation Wednesday,and finished chemotherapy last week.The radiation was particularly painful,causing him to lose the skin from the roof of his mouth.He had to be fed through a tube.
His wife,Jill Kelly,tweeted the following:
At 1 pm today!IT IS FINISHED!
GLORY TO GOD!!!!
DONE!
She went on to tweet:
High Fives.Tears.And A LOT OF THANKS AND PRAISE!!!!
Again,THANK YOU FOR PRAYING!*
Next will be two to three months of assessment to deteremine if more surgery will be needed.Jim underwent his first operation last June.The squamous cell carcinoma returned and started to spread up his orbital nerve.
This blog will stay on the story.
Showing posts with label chemotherapy. Show all posts
Showing posts with label chemotherapy. Show all posts
Friday, May 30, 2014
Friday, April 4, 2014
NFL Great Jim Kelly's Cancer Treatment Set
The beloved former Buffalo Bills quarterback Jim Kelly,who led the NFL team to four consecutive Super Bowls from 1991-94,remains in New York's Lenox Hill Hospital,where he is scheduled to begin treatment for his aggressive head and neck cancer next Monday.He has endured a lot of pain and weakness recently,but is still determined to regain his health,bolstered by strong support and prayers from family and his Western New York fan base.
Last summer,part of Jim's jaw and some teeth were removed during oral surgery for a squamous cell carcinoma.Since then,however,the cancer has reportedly started to spread countless microscopic tumors up the infraorbital nerve,dangerously close to the carotid artery.Jim said he had complained about his headaches for months,but thought they were just part of healing from his June 2013 surgery.Routine testing recently diagnosed the recurring malignancy.*
In an April 1 statement on Jim's condition released by Lenox Hill Hospital,Peter Constantino,MD,executive director of the New York Head&Neck Institute,said Jim will start treatment next week targeting cancer cells in his maxillary sinus and adjacent tissues.He will receive a single dose of chemotherapy along with concurrent daily radiation treatments.The chemotherapy will be repeated on an outpatient basis in about three and six weeks.The radiation therapy will be a six week regimen at North Shore LIJ Cancer Institute Center for Advanced Medicine in Lake Success,New York,which has a new,47 million dollar,30,000 square foot radiation medicine faciltity that opened earlier this year.
At the conclusion of these treatments,we will wait two to three months to determine the status of his cancer before deciding if surgery will be necessary,Dr.Constantino said.I am confident that this current regimen has a good chance of successfully impacting Jim's cancer.
As I have stated previously,Jim Kelly's condition remains very treatable and potentially curable.Even if chemotherapy and radiation are not successful in eradicating the cancer,his skull-base tumor remains operable,the leading authority on cranial base tumor surgery and facial reconstruction concluded.
Head and neck cancer has been linked to tobacco use,heavy drinking and the human papilloma virus.
Last summer,part of Jim's jaw and some teeth were removed during oral surgery for a squamous cell carcinoma.Since then,however,the cancer has reportedly started to spread countless microscopic tumors up the infraorbital nerve,dangerously close to the carotid artery.Jim said he had complained about his headaches for months,but thought they were just part of healing from his June 2013 surgery.Routine testing recently diagnosed the recurring malignancy.*
In an April 1 statement on Jim's condition released by Lenox Hill Hospital,Peter Constantino,MD,executive director of the New York Head&Neck Institute,said Jim will start treatment next week targeting cancer cells in his maxillary sinus and adjacent tissues.He will receive a single dose of chemotherapy along with concurrent daily radiation treatments.The chemotherapy will be repeated on an outpatient basis in about three and six weeks.The radiation therapy will be a six week regimen at North Shore LIJ Cancer Institute Center for Advanced Medicine in Lake Success,New York,which has a new,47 million dollar,30,000 square foot radiation medicine faciltity that opened earlier this year.
At the conclusion of these treatments,we will wait two to three months to determine the status of his cancer before deciding if surgery will be necessary,Dr.Constantino said.I am confident that this current regimen has a good chance of successfully impacting Jim's cancer.
As I have stated previously,Jim Kelly's condition remains very treatable and potentially curable.Even if chemotherapy and radiation are not successful in eradicating the cancer,his skull-base tumor remains operable,the leading authority on cranial base tumor surgery and facial reconstruction concluded.
Head and neck cancer has been linked to tobacco use,heavy drinking and the human papilloma virus.
Thursday, November 4, 2010
Commentary:Couple Chucks Lotto Jackpot
A retired welder and retail worker have given away most of their 11.3 million dollar Canadian lottery winnings.Allen and Violet Large,of Nova Scotia,were appalled by panhandlers coming out of the woodwork when their good fortune became known.
As well,Mrs.Large,78,has recently undergone chemotherapy for her cancer.The great suffering of that disease tends to put things in the proper perspective.So does their rural lifestyle.
It wouldn't hurt financiers to contemplate the Larges now and again.The business world might benefit from such an exercise.Maybe it would help to prevent another financial crisis.
A 2-page list of charities,including hospitals,churches,the Red Cross and the fire department,were beneficiaries of the Larges' generosity.
That doesn't mean you shouldn't strive to better yourselves.A little bit of context leads to better health all round,that's all.The true texture of life is easily and sadly forgotten in the daily scrum.
We should be grateful for the Larges' big hearts,which were already well-known in their community.They can ennoble our own,however far away.
As well,Mrs.Large,78,has recently undergone chemotherapy for her cancer.The great suffering of that disease tends to put things in the proper perspective.So does their rural lifestyle.
It wouldn't hurt financiers to contemplate the Larges now and again.The business world might benefit from such an exercise.Maybe it would help to prevent another financial crisis.
A 2-page list of charities,including hospitals,churches,the Red Cross and the fire department,were beneficiaries of the Larges' generosity.
That doesn't mean you shouldn't strive to better yourselves.A little bit of context leads to better health all round,that's all.The true texture of life is easily and sadly forgotten in the daily scrum.
We should be grateful for the Larges' big hearts,which were already well-known in their community.They can ennoble our own,however far away.
Thursday, October 21, 2010
Frontiers In Medicine:Genentech's Cancer Treatment Approved
The FDA has approved Genentech's biotech medicine Herceptin,in combination with chemotherapy,as a treatment for certain stomach cancers-metastatic ones with the protein HER2 on tumor cells.
Early studies suggest Herceptin may block signals that cause tumor cells to grow and divide,and also signals the immune system to destroy the cancer cells.
About 21,000 Americans will be diagnosed with stomach cancer in 2010,and more than 10,500 will die of it.Often,symptoms of the disease do not appear until the late stages,when it has become metastatic,or spreading,or cannot be surgically removed.
The latest analysis shows that median overall survival with the Herceptin/chemotherapy regimen was 13.1 months,versus 11.7 months with chemotherapy alone.Herceptin is also used to treat HER2+ metastatic breast cancer.
Hal Barron,M.D.,executive vice president of Product Development and chief medical officer,said the FDA approval provides an important new personalized medicine for people with the life-threatening disease who have few treatment options.
Formerly an independent firm,Genentech became a member of Switzerland's Roche Group in March 2009.Considered the original biotech company,Genentech uses human genetic information to discover,develop,manufacture and commercialize medicines for gravely ill patients.
The Roche Group is traded on the over the counter pink sheets in the U.S.,under the ticker symbol RHHBY.
Early studies suggest Herceptin may block signals that cause tumor cells to grow and divide,and also signals the immune system to destroy the cancer cells.
About 21,000 Americans will be diagnosed with stomach cancer in 2010,and more than 10,500 will die of it.Often,symptoms of the disease do not appear until the late stages,when it has become metastatic,or spreading,or cannot be surgically removed.
The latest analysis shows that median overall survival with the Herceptin/chemotherapy regimen was 13.1 months,versus 11.7 months with chemotherapy alone.Herceptin is also used to treat HER2+ metastatic breast cancer.
Hal Barron,M.D.,executive vice president of Product Development and chief medical officer,said the FDA approval provides an important new personalized medicine for people with the life-threatening disease who have few treatment options.
Formerly an independent firm,Genentech became a member of Switzerland's Roche Group in March 2009.Considered the original biotech company,Genentech uses human genetic information to discover,develop,manufacture and commercialize medicines for gravely ill patients.
The Roche Group is traded on the over the counter pink sheets in the U.S.,under the ticker symbol RHHBY.
Subscribe to:
Posts (Atom)